Responding to questions on gene tech

// B+LNZ

Farmers have asked B+LNZ for more information on the complex topic of gene technology.

image of lab and tech analysing sample

Background 

Immediately before Christmas last year, Parliament’s Health Committee called for submissions on the Gene Technology Bill 2024, giving the public eight weeks (including the summer holidays) to make a submission on this important issue. 

B+LNZ was frustrated by this timing and, with other sector groups, pushed the Government to provide more time so we could properly consult with our farmers. This request was refused. You can read more about the submission we provided despite these challenges in our recent e-diary story here.  

In the meantime, B+LNZ has been asked by farmers for more information on gene technology – what it is, what the potential risks exist are and where the opportunities lie. This is understandable, as it is a complex and divisive topic.  

If the Government had allowed more time to consider the proposed legislation, B+LNZ’s preference would then have been for the primary sector to collaborate on setting out the risks and opportunities of gene technology for our sector and get input from producers to ensure a holistic and informed view of the legislation. 

In the absence of this, we provide some further reading for farmers.  

Further reading 

This is not a comprehensive list but should help outline some of the important aspects of the gene technology debate.  

Our work 

B+LNZ’s Select Committee submission identified a range of risks that need to be managed in relation to gene technology but that are not clearly addressed in the Bill – particularly market access, traceability, coexistence and risk management. 

We are writing again to the Health Select Committee asking for the Government to slow down this process so we can properly consider and address the wide range of farmer views and ensure we get this important legislation right.